R/R AML

Clinical trials for R/R AML explained in plain language.

Never miss a new study

Get alerted when new R/R AML trials appear

Sign up with your email to follow new studies for R/R AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New cell therapy targets tough leukemia

Disease control Not yet recruiting

This early-phase study tests a new type of immune cell therapy (CAR-ITNK cells) designed to attack two specific targets on leukemia cells. It is for adults aged 18 to 75 with acute myeloid leukemia that has returned or not responded to standard treatment. Participants receive a s…

Matched conditions: R/R AML

Phase: EARLY_PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control

Last updated Jun 10, 2026 13:27 UTC

R/R AML

Get alerted when new R/R AML trials appear

New cell therapy targets tough leukemia